1. Secretory expression of a novel human spermatozoa antigen in E. coli and its application to a protein chip
- Author
-
Qiu Zhuolin, Jingjing Li, Mingzhu Wang, Ying-song Wu, Xiangsheng Cai, Yuan-feng Xu, and She Miaoqin
- Subjects
Male ,0301 basic medicine ,Protein Array Analysis ,Enzyme-Linked Immunosorbent Assay ,Bioengineering ,Peptide ,medicine.disease_cause ,Applied Microbiology and Biotechnology ,law.invention ,03 medical and health sciences ,Antigen ,law ,Escherichia coli ,medicine ,Humans ,Antigens ,Infertility, Male ,Autoantibodies ,chemistry.chemical_classification ,biology ,urogenital system ,Escherichia coli Proteins ,Autoantibody ,General Medicine ,Alkaline Phosphatase ,Spermatozoa ,Molecular biology ,Recombinant Proteins ,030104 developmental biology ,chemistry ,Area Under Curve ,Recombinant DNA ,biology.protein ,Alkaline phosphatase ,Antibody ,Biotechnology - Abstract
To produce a recombinant spermatozoa antigen peptide using the E. coli: PhoA system on a protein chip for screening anti-sperm antibodies (ASA). The purity of the recombinant spermatozoa antigen exceeded 95% after two-step purification, as assessed using SDS-PAGE and HPLC. The diagnostic performance of a protein chip coated with the recombinant antigen peptide was evaluated by examining ASA in 51 infertile patients in comparison with a commercial ELISA kit. The area under the receiver operating characteristic curve (AUC) was 0.944, which indicated that the protein chip coated with recombinant spermatozoa antigen peptide was consistent with ELISA for ASA detection. A recombinant spermatozoa antigen was expressed in the E. coli PhoA secretory expression system and its potential application for clinical ASA detection was validated.
- Published
- 2017
- Full Text
- View/download PDF